On February 4, 2026, an expert presentation on the characteristics of the drug IG Vena was held at the Clinic for Neurology and Psychiatry for Children and Youth, University Clinical Center of Serbia. Representative of Magna Pharmacia d.o.o. The U.S. Department of Homeland Security presented key information about the drug IG Vena, with special emphasis on the composition, indications, method of administration, safety profile and clinical benefits in therapy. The presentation was attended by physicians specializing in the field of pediatric neurology, epileptology and child psychiatry, as well as pharmacists, with whom a professional and constructive discussion was held on the therapeutic possibilities and practical aspects of the use of intravenous immunoglobulin – IG Veins in everyday clinical practice. Expert meetings of this type contribute to the improvement of the provision of health services, the quality of therapy and patient safety.